Product Code: A01044
The global Biosurgery market was valued at $11,425.5 million in 2020, and is projected to reach $27,324.8 million by 2030, registering a CAGR of 9.1% from 2021 to 2030.
Biosurgery products consist of synthetic, semisynthetic or natural material that help in tissue repair and seal surgical incision. Biosurgery products are used in various surgeries to minimize the intra and post-operative complications. Biosurgery products also help facilitate tissue sealing hemostasis. Moreover, biosurgery products are used in hard tissue regeneration in ortho-biologics. Various synthetic and biologic products, such as anti-adhesive agents, hemostatic agents, surgical sealing agents, bone graft substitutes, and soft tissue management are utilized in surgeries for prevention of excessive blood loss or providing adhesion or wound/tissue sealing.
The growth of the global biosurgery market is majorly driven by increase in prevalence of chronic disease, trauma, rise in government and private organizations initiatives for development of the medical devices sector, surge in number of surgical procedures, and rise in demand for biosurgery products.
Furthermore, rise in number of geriatric population drives the growth of the market. This is attributed to the fact that geriatric population is highly vulnerable to chronic diseases, which boosts the need for various surgical procedure and upsurge the demand for biosurgery products. This factor is expected to notably contribute toward the growth of the global biosurgery market.
In addition, increase in sports-related injuries and surgeries, increase in sedentary lifestyle, and rise in several approvals for biosurgery, drive the growth of the global biosurgery market.
In addition, increase in R&D activities in the healthcare industry and rise in blood loss management systems are anticipated to provide lucrative opportunities for the market expansion.
However, high cost of biosurgery products and stringent government regulations hinder the market growth. On the contrary, increase in awareness among physicians and researchers about the use of biosurgery products augments the growth of the biosurgery market. This has further encouraged many key players to enter emerging markets, thus offering lucrative opportunities for the expansion of the biosurgery market.
The biosurgery market is segmented on the basis of product type, application, source, and region. Depending on the product type, the market is divided into anti-adhesive agents, hemostatic agents and surgical sealants, bone graft substitutes, and mesh (soft tissue management). On the basis of application, the market is segmented into cardiovascular and thoracic, neuro and spine surgery, orthopedic surgery, and general surgery. On the basis of source, the market is segmented into biologics products, and synthetic products. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global biosurgery market are Aroa Biosurgery Limited, B. Braun Melsungen AG, Baxter International Inc., BD (Becton, Dickinson and Company), Hemostasis LLC, Integra LifeSciences Holdings Corp., Johnson and Johnson, Medtronic PLC, Sanofi S.A., Tissue Regenix Groups.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the biosurgery market analysis from 2020 to 2030 to identify the prevailing biosurgery market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the biosurgery market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global biosurgery market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product Type
- Anti Adhesive Agents
- Bone Graft Substitutes
- Hemostatic And Surgical Sealant
- Mesh
By Application
- Cardiovascular And Thoracic Surgery
- Neuro And Spine Surgery
- Orthopedic Surgery
- General Surgery
By Source
- Biologics Products
- Synthetic Products
By Region
- North America
- Europe
- Germany
- France
- United Kingdom
- Rest of Europe
- Asia-Pacific
- China
- Japan
- Australia
- India
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Turkey
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- aroa biosurgery limited
- Baxter International Inc.
- B. BRAUN MELSUNGEN AG
- Becton, Dickinson and Company
- HEMOSTASIS LLC
- INTEGRA LIFE SCIENCES HOLDINGS CORP
- JOHNSON and JOHNSON SERVICES, INC.
- Medtronic, Inc.
- SANOFI S A
- TISSUE REGENIX GROUP
TABLE OF CONTENTS
CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter's five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: BIOSURGERY MARKET, BY PRODUCT TYPE
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Anti Adhesive Agents
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Bone Graft Substitutes
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.4 Hemostatic And Surgical Sealant
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
- 4.5 Mesh
- 4.5.1 Key market trends, growth factors and opportunities
- 4.5.2 Market size and forecast, by region
- 4.5.3 Market analysis by country
CHAPTER 5: BIOSURGERY MARKET, BY APPLICATION
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Cardiovascular And Thoracic Surgery
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Neuro And Spine Surgery
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Orthopedic Surgery
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- 5.5 General Surgery
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
CHAPTER 6: BIOSURGERY MARKET, BY SOURCE
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Biologics Products
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Synthetic Products
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
CHAPTER 7: BIOSURGERY MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Product Type
- 7.2.3 North America Market size and forecast, by Application
- 7.2.4 North America Market size and forecast, by Source
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Market size and forecast, by Product Type
- 7.2.5.1.2 Market size and forecast, by Application
- 7.2.5.1.3 Market size and forecast, by Source
- 7.2.5.2 Canada
- 7.2.5.2.1 Market size and forecast, by Product Type
- 7.2.5.2.2 Market size and forecast, by Application
- 7.2.5.2.3 Market size and forecast, by Source
- 7.2.5.3 Mexico
- 7.2.5.3.1 Market size and forecast, by Product Type
- 7.2.5.3.2 Market size and forecast, by Application
- 7.2.5.3.3 Market size and forecast, by Source
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Product Type
- 7.3.3 Europe Market size and forecast, by Application
- 7.3.4 Europe Market size and forecast, by Source
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Market size and forecast, by Product Type
- 7.3.5.1.2 Market size and forecast, by Application
- 7.3.5.1.3 Market size and forecast, by Source
- 7.3.5.2 France
- 7.3.5.2.1 Market size and forecast, by Product Type
- 7.3.5.2.2 Market size and forecast, by Application
- 7.3.5.2.3 Market size and forecast, by Source
- 7.3.5.3 United Kingdom
- 7.3.5.3.1 Market size and forecast, by Product Type
- 7.3.5.3.2 Market size and forecast, by Application
- 7.3.5.3.3 Market size and forecast, by Source
- 7.3.5.4 Rest of Europe
- 7.3.5.4.1 Market size and forecast, by Product Type
- 7.3.5.4.2 Market size and forecast, by Application
- 7.3.5.4.3 Market size and forecast, by Source
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Product Type
- 7.4.3 Asia-Pacific Market size and forecast, by Application
- 7.4.4 Asia-Pacific Market size and forecast, by Source
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 China
- 7.4.5.1.1 Market size and forecast, by Product Type
- 7.4.5.1.2 Market size and forecast, by Application
- 7.4.5.1.3 Market size and forecast, by Source
- 7.4.5.2 Japan
- 7.4.5.2.1 Market size and forecast, by Product Type
- 7.4.5.2.2 Market size and forecast, by Application
- 7.4.5.2.3 Market size and forecast, by Source
- 7.4.5.3 Australia
- 7.4.5.3.1 Market size and forecast, by Product Type
- 7.4.5.3.2 Market size and forecast, by Application
- 7.4.5.3.3 Market size and forecast, by Source
- 7.4.5.4 India
- 7.4.5.4.1 Market size and forecast, by Product Type
- 7.4.5.4.2 Market size and forecast, by Application
- 7.4.5.4.3 Market size and forecast, by Source
- 7.4.5.5 Rest of Asia-Pacific
- 7.4.5.5.1 Market size and forecast, by Product Type
- 7.4.5.5.2 Market size and forecast, by Application
- 7.4.5.5.3 Market size and forecast, by Source
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Product Type
- 7.5.3 LAMEA Market size and forecast, by Application
- 7.5.4 LAMEA Market size and forecast, by Source
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Brazil
- 7.5.5.1.1 Market size and forecast, by Product Type
- 7.5.5.1.2 Market size and forecast, by Application
- 7.5.5.1.3 Market size and forecast, by Source
- 7.5.5.2 Turkey
- 7.5.5.2.1 Market size and forecast, by Product Type
- 7.5.5.2.2 Market size and forecast, by Application
- 7.5.5.2.3 Market size and forecast, by Source
- 7.5.5.3 Saudi Arabia
- 7.5.5.3.1 Market size and forecast, by Product Type
- 7.5.5.3.2 Market size and forecast, by Application
- 7.5.5.3.3 Market size and forecast, by Source
- 7.5.5.4 South Africa
- 7.5.5.4.1 Market size and forecast, by Product Type
- 7.5.5.4.2 Market size and forecast, by Application
- 7.5.5.4.3 Market size and forecast, by Source
- 7.5.5.5 Rest of LAMEA
- 7.5.5.5.1 Market size and forecast, by Product Type
- 7.5.5.5.2 Market size and forecast, by Application
- 7.5.5.5.3 Market size and forecast, by Source
CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
CHAPTER 9: COMPANY PROFILES
- 9.1 aroa biosurgery limited
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 Baxter International Inc.
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 B. BRAUN MELSUNGEN AG
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 Becton, Dickinson and Company
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 HEMOSTASIS LLC
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 INTEGRA LIFE SCIENCES HOLDINGS CORP
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 JOHNSON and JOHNSON SERVICES, INC.
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 Medtronic, Inc.
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 SANOFI S A
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 TISSUE REGENIX GROUP
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments